How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study

被引:60
作者
Fischer, BM [1 ]
Olsen, MWB
Ley, CD
Klausen, TL
Mortensen, J
Hojgaard, L
Kristjansen, PEG
机构
[1] Copenhagen Univ Hosp, Dept Clin Phsyiol Nucl Med & PET, Copenhagen, Denmark
[2] Univ Copenhagen, Lab Expt Oncol Mol Pathol, Copenhagen, Denmark
[3] Herlev Univ Hosp, Dept Clin Physiol, DK-2730 Herlev, Denmark
关键词
positron emission tomography; detection limit; cancer; malignant cells; number;
D O I
10.1007/s00259-005-0038-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Positron emission tomography ( PET) has gained widespread use in cancer diagnosis and treatment, but how many malignant cells are required for a tumour to be detected by PET? Methods: Three human cancer cell lines [ glioblastoma and two subtypes of small cell lung cancer (SCLC)] in concentrations from 10(4) to 10(7) were seeded on six-well plates or plastic tubes and treated with [F-18] fluorodeoxyglucose (FDG) in vitro. FDG retention was measured in a PET/CT scanner and in a calibrated well counter. The clinical situation was simulated using a cylinder phantom with a background concentration of FDG. Results: The theoretical detection limit was found to be around 10(5) malignant cells. In a cylinder phantom the detection limit was increased by a factor of 10. The FDG retention by the glioblastoma cell line was significantly higher than the activity of the SCLC cell line. FDG retention measured by PET and a gamma counter was closely correlated to the number of cells and a linear relationship was found. Discussion: The detection limit of PET is in the magnitude of 10(5) to 10(6) malignant cells. The experimental set-up was robust and well suited as a platform for further investigations of factors influencing the detection limit of PET.
引用
收藏
页码:697 / 702
页数:6
相关论文
共 12 条
[1]  
CHERRY SR, 1995, DIAGNOSTIC NUCL MED, V1, P139
[2]   NATURAL-HISTORY OF LUNG-CANCER - REVIEW BASED ON RATES OF TUMOR-GROWTH [J].
GEDDES, DM .
BRITISH JOURNAL OF DISEASES OF THE CHEST, 1979, 73 (01) :1-17
[3]  
HABERKORN U, 1994, J NUCL MED, V35, P1842
[4]   Positron-emission tomography with [18F]fluorodeoxyglucose Part I.: Biochemical uptake mechanism and its implication for clinical studies [J].
Pauwels, EKJ ;
Sturm, EJC ;
Bombardieri, E ;
Cleton, FJ ;
Stokkel, MPM .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (10) :549-559
[5]   Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro [J].
Pedersen, MWB ;
Holm, S ;
Lund, EL ;
Hojgaard, L ;
Kristjansen, PEG .
NEOPLASIA, 2001, 3 (01) :80-87
[6]   Evaluation of ion-implanted-silicon detectors for use in intraoperative positron-sensitive probes [J].
Raylman, RR ;
Wahl, RL .
MEDICAL PHYSICS, 1996, 23 (11) :1889-1895
[7]   Endoprobe: A system for radionuclide-guided endoscopy [J].
Raylman, RR ;
Srinivasan, A .
MEDICAL PHYSICS, 2004, 31 (12) :3306-3313
[8]   Role of F18-FDG PET for monitoring of radiochemotherapy -: Estimation of detectable number of tumour cells [J].
Ruf, J ;
Amthauer, H ;
Oettle, H ;
Steinmüller, T ;
Plotkin, M ;
Pelzer, U ;
Scholman, HJ ;
Felix, R ;
Wust, P .
ONKOLOGIE, 2004, 27 (03) :287-290
[9]   Positron emission tomography in lung cancer [J].
Shon, IH ;
O'Doherty, MJ ;
Maisey, MN .
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (04) :240-271
[10]   Quantitation of cell number by a positron emission tomography reporter gene strategy [J].
Su, H ;
Forbes, A ;
Gambhir, SS ;
Braun, J .
MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (03) :139-148